StonvexLoading…
StonvexCore line items from WDS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.98B | $13.18B | $13.99B | $16.82B |
Operating Income | $3.89B | $4.51B | $3.31B | $9.19B |
Net Income | $2.74B | $3.65B | $1.72B | $6.58B |
EPS (Diluted) | $1.42 | $1.87 | $0.87 | $4.26 |
Total Assets | $66.50B | $61.26B | $55.36B | $59.32B |
Total Liabilities | $26.66B | $25.11B | $20.19B | $22.19B |
Cash & Equivalents | $5.71B | $3.92B | $1.74B | $6.20B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |